175 related articles for article (PubMed ID: 17474150)
1. Bacillus subtilis spores: a novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen.
Barnes AG; Cerovic V; Hobson PS; Klavinskis LS
Eur J Immunol; 2007 Jun; 37(6):1538-47. PubMed ID: 17474150
[TBL] [Abstract][Full Text] [Related]
2. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
[TBL] [Abstract][Full Text] [Related]
3. Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine.
Song M; Hong HA; Huang JM; Colenutt C; Khang DD; Nguyen TV; Park SM; Shim BS; Song HH; Cheon IS; Jang JE; Choi JA; Choi YK; Stadler K; Cutting SM
Vaccine; 2012 May; 30(22):3266-77. PubMed ID: 22446640
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S
Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
[TBL] [Abstract][Full Text] [Related]
6. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
[TBL] [Abstract][Full Text] [Related]
7. Systemic and local mucosal immune responses induced by orally delivered Bacillus subtilis spore expressing leucine aminopeptidase 2 of Clonorchis sinensis.
Qu H; Xu Y; Sun H; Lin J; Yu J; Tang Z; Shen J; Liang C; Li S; Chen W; Li X; Wu Z; Huang Y; Yu X
Parasitol Res; 2014 Aug; 113(8):3095-103. PubMed ID: 24906994
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G).
Morris CB; Cheng E; Thanawastien A; Cárdenas-Freytag L; Clements JD
Vaccine; 2000 Mar; 18(18):1944-51. PubMed ID: 10699345
[TBL] [Abstract][Full Text] [Related]
9. Mucosal Vaccination With Recombinant
Wei J; Hegde VL; Yanamandra AV; O'Hara MP; Keegan B; Jones KM; Strych U; Bottazzi ME; Zhan B; Sastry KJ; Hotez PJ
Front Immunol; 2022; 13():800295. PubMed ID: 35197976
[TBL] [Abstract][Full Text] [Related]
10. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
[TBL] [Abstract][Full Text] [Related]
12. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
[TBL] [Abstract][Full Text] [Related]
13. Bacillus subtilis spores as adjuvants for DNA vaccines.
Aps LR; Diniz MO; Porchia BF; Sales NS; Moreno AC; Ferreira LC
Vaccine; 2015 May; 33(20):2328-34. PubMed ID: 25819710
[TBL] [Abstract][Full Text] [Related]
14. The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid.
Barisani-Asenbauer T; Inic-Kanada A; Belij S; Marinkovic E; Stojicevic I; Montanaro J; Stein E; Bintner N; Stojanovic M
PLoS One; 2013; 8(4):e60682. PubMed ID: 23637758
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.
Takahashi I; Marinaro M; Kiyono H; Jackson RJ; Nakagawa I; Fujihashi K; Hamada S; Clements JD; Bost KL; McGhee JR
J Infect Dis; 1996 Mar; 173(3):627-35. PubMed ID: 8627026
[TBL] [Abstract][Full Text] [Related]
16. The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant.
Liu X; Wetzler LM; Massari P
Vaccine; 2008 Feb; 26(6):786-96. PubMed ID: 18191311
[TBL] [Abstract][Full Text] [Related]
17. Oral priming of mice by recombinant spores of Bacillus subtilis.
Ciabattini A; Parigi R; Isticato R; Oggioni MR; Pozzi G
Vaccine; 2004 Oct; 22(31-32):4139-43. PubMed ID: 15474704
[TBL] [Abstract][Full Text] [Related]
18. RANTES potentiates antigen-specific mucosal immune responses.
Lillard JW; Boyaka PN; Taub DD; McGhee JR
J Immunol; 2001 Jan; 166(1):162-9. PubMed ID: 11123289
[TBL] [Abstract][Full Text] [Related]
19. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 12 and innate molecules for enhanced mucosal immunity.
Boyaka PN; Lillard JW; McGhee J
Immunol Res; 1999; 20(3):207-17. PubMed ID: 10741861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]